People v. Estrada
REVERSALFacts
The Antecedents: The Supreme Court previously denied a petition questioning a trial court's order which quashed a search warrant and ordered the return of seized goods due to the warrant's failure to satisfy constitutional requirements. The seized goods consisted of 52 boxes of medicines. Procedural History: The trial court quashed the search warrant and ordered the return of seized goods. The Supreme Court initially denied a petition questioning this order. The Petition: Petitioner seeks partial reconsideration, arguing that the seized drugs, subject of the void warrant, are contraband and thus cannot be returned. Annexes attached to the motion purportedly show that the seized medicines were genuine but illegally imported, lacking proper permits from the Bureau of Foods and Drugs (BFAD).
Issue(s)
Whether seized drugs, even if pharmaceutically genuine, can be returned when they are contraband due to lack of proper permits or authority from the Bureau of Foods and Drugs (BFAD). Whether the pharmaceutical genuineness of seized drugs is sufficient justification for their return despite lacking legal documentation.
Ruling
The Partial Motion for Reconsideration is GRANTED. The Solicitor General is directed to notify the BFAD to dispose of the seized 52 boxes of drugs and medicines within a specified period, and to report the matter to the Court.
Ratio Decidendi
On the issue of returning seized drugs lacking permits: The Court held that even if the medicines or drugs seized were genuine and contained the proper chemicals, they cannot be returned if the producer, manufacturer, or seller has no permit or authority from the appropriate government agency, such as the Bureau of Foods and Drugs (BFAD). The Court emphasized that the State has an obligation to protect and promote the right to health of the people and to supervise and control the proliferation of drugs in the market, as mandated by the Constitution. The policy of the law, enunciated in R.A. No. 8203, is to protect consumers and licensed businessmen. Therefore, the pharmaceutical genuineness of the drugs is not a sufficient justification for their return; there must be compliance with the requirements of the law regarding permits and licenses. The Court noted that the private respondent could not rely on the trial court's statement that the applicant failed to allege the drugs were fake, misbranded, adulterated, or unregistered, as the illegality stemmed from the lack of appropriate permits. On the sufficiency of pharmaceutical genuineness for return: The Court ruled that pharmaceutical genuineness alone is not a sufficient justification to demand the return of seized drugs. While laboratory examinations can determine genuineness, the therapeutic quality of drug products is not evident to end-users who rely on prescriptions and availability in drug stores. The Court stressed that knowledge in drug production is not readily available to the public, and the State's mandate to establish and maintain an effective food and drug regulatory system cannot be neglected. The BFAD is vested by law with the authority to make a mandatory determination of the true therapeutic effect of drugs, involving technical skill within its special competence. The health of the citizenry should never be compromised, and seized drugs that are pharmaceutically correct but not properly documented should be disposed of according to law to prevent them from falling into the wrong hands.
Main Doctrine
Seized drugs, even if pharmaceutically genuine, cannot be returned if they are contraband due to lack of proper permits or authority from the Bureau of Foods and Drugs (BFAD), as the State has an obligation to protect public health and regulate the proliferation of drugs in the market.